Back

Emerging knowledge on cardiorenal protection.

26 May 2019 (13:05 - 13:15)
Organised by:
Congress Presentation Part of: Sodium–glucose co-transporter 2 inhibition and the heart: lessons from cardiovascular outcomes trials in Type 2 diabetes (EBAC Accredited) Renal Failure and Cardiovascular Disease HFA Premium Access Heart Failure 2019

About the speaker

Photo
Professor Subodh Verma

St. Michael's Hospital, Toronto (Canada)

5 More presentations in this session

Presentation thumbnail
Welcome and introductions - Sodium–glucose co-transporter 2 inhibition and the heart: lessons from cardiovascular outcomes trials in Type 2 diabetes.
Professor A. Mebazaa (Paris, FR)
Presentation thumbnail
What have cardiovascular outcomes trials taught us about cardiovascular risk management?
Professor M. Pfeffer (Boston, US)
Presentation thumbnail
From classroom to clinic: sodium–glucose co-transporter 2 inhibitor evidence in practice.
Professor S. Verma (Toronto, CA) Professor M. Cowie (London, GB) Doctor S. Wiviott (Boston, US) Professor A. Mebazaa (Paris, FR)
Presentation thumbnail
What we still need to learn from sodium–glucose co-transporter 2 inhibitors to predict the future.
Professor M. Cowie (London, GB)
Presentation thumbnail
Q&A - Sodium–glucose co-transporter 2 inhibition and the heart: lessons from cardiovascular outcomes trials in Type 2 diabetes.
Professor M. Cowie (London, GB) Professor S. Verma (Toronto, CA) Professor M. Pfeffer (Boston, US) Professor A. Mebazaa (Paris, FR)

Access the full session

Session thumbnail
Sodium–glucose co-transporter 2 inhibition and the heart: lessons from cardiovascular outcomes trials in Type 2 diabetes (EBAC Accredited)

The Event

Event poster

Heart Failure 2019

26 May 2019 13:05 CET
You may be interested in
thumbnail
Congress Presentation
GLP1 receptor agonists, SGLT2 inhibitors, or both for cardio-renal protection?
30 August 2024
thumbnail
Congress Presentation
Target dose of heart failure medications is associated with better mortality/morbidity: data from the Swedish Heart Failure Registry
29 June 2021
thumbnail
Congress Presentation
1 September 2019
thumbnail
Congress Presentation
Design of the trial DAPAgliflozin for Renal protection in Heart Transplant recipients (DAPARHT)
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources